These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


122 related items for PubMed ID: 7948606

  • 21. Analysis of the mechanism of graft-versus-host-like disease in B6 mice with transferred B6-lpr spleen cells.
    Matsunaga T, Kobayashi S, Harada H, Kawaguchi Y, Wang W, Okuyama H.
    Autoimmunity; 1991; 8(4):307-15. PubMed ID: 1718458
    [Abstract] [Full Text] [Related]

  • 22. Fas-deficient lpr mice are more susceptible to graft-versus-host disease.
    van Den Brink MR, Moore E, Horndasch KJ, Crawford JM, Hoffman J, Murphy GF, Burakoff SJ.
    J Immunol; 2000 Jan 01; 164(1):469-80. PubMed ID: 10605044
    [Abstract] [Full Text] [Related]

  • 23. Intra-bone marrow injection of allogeneic bone marrow cells: a powerful new strategy for treatment of intractable autoimmune diseases in MRL/lpr mice.
    Kushida T, Inaba M, Hisha H, Ichioka N, Esumi T, Ogawa R, Iida H, Ikehara S.
    Blood; 2001 May 15; 97(10):3292-9. PubMed ID: 11342461
    [Abstract] [Full Text] [Related]

  • 24. Participation of NK1.1+ T cells in the rejection of lpr alphabetaT cells when bone marrow cells of lpr mice are transplanted into B6 mice.
    Tsukahara A, Kawamura H, Iiai T, Moroda T, Suzuki S, Tada T, Minagawa M, Musha N, Hatakeyama K, Abo T.
    Microbiol Immunol; 1998 May 15; 42(6):447-56. PubMed ID: 9688079
    [Abstract] [Full Text] [Related]

  • 25. Immunomodulation of autoimmunity in MRL/lpr mice with syngeneic bone marrow transplantation (SBMT).
    Karussis DM, Vourka-Karussis U, Lehmann D, Abramsky O, Ben-Nun A, Slavin S.
    Clin Exp Immunol; 1995 Apr 15; 100(1):111-7. PubMed ID: 7697909
    [Abstract] [Full Text] [Related]

  • 26. Treatment of intractable autoimmune diseases in MRL/lpr mice using a new strategy for allogeneic bone marrow transplantation.
    Kushida T, Inaba M, Takeuchi K, Sugiura K, Ogawa R, Ikehara S.
    Blood; 2000 Mar 01; 95(5):1862-8. PubMed ID: 10688849
    [Abstract] [Full Text] [Related]

  • 27. Reconstitution of lymphoid tissues under the influence of a subclinical level of graft versus host reaction induced by bone marrow T cells or splenic T cell subsets.
    Hirano M, Arase H, Arase-Fukushi N, Ogasawara K, Iwabuchi K, Miyazaki T, Good RA, Onoé K.
    Cell Immunol; 1993 Oct 01; 151(1):118-32. PubMed ID: 8402923
    [Abstract] [Full Text] [Related]

  • 28. A new strategy for treatment of malignant tumor: intra-bone marrow-bone marrow transplantation plus CD4- donor lymphocyte infusion.
    Suzuki Y, Adachi Y, Minamino K, Zhang Y, Iwasaki M, Nakano K, Koike Y, Ikehara S.
    Stem Cells; 2005 Mar 01; 23(3):365-70. PubMed ID: 15749931
    [Abstract] [Full Text] [Related]

  • 29. Graft-versus-host disease in murine bone marrow transplantation. I. Modification of GVHD by preimmunization of recipients with spleen cells of primary recipients undergoing GVHD.
    Gorczynski RM, Kennedy M, Robillard M.
    Immunol Lett; 1985 Mar 01; 11(5-6):281-91. PubMed ID: 2936680
    [Abstract] [Full Text] [Related]

  • 30. Treatment of autoimmune MRL/Ipr mice with monoclonal antibody to Thy-1.2: a single injection has sustained effects on lymphoproliferation and renal disease.
    Seaman WE, Wofsy D, Greenspan JS, Ledbetter JA.
    J Immunol; 1983 Apr 01; 130(4):1713-8. PubMed ID: 6187819
    [Abstract] [Full Text] [Related]

  • 31. Prevention of cyclosporine-induced syngeneic graft-versus-host disease in bone marrow transplantation by UV-B irradiated bone marrow cells.
    Ohajekwe OA, James T, Hardy MA, Oluwole SF.
    Bone Marrow Transplant; 1995 Apr 01; 15(4):627-32. PubMed ID: 7655391
    [Abstract] [Full Text] [Related]

  • 32. Analysis of cytokine production and V beta T-cell receptor subsets in irradiated recipients receiving portal or peripheral venous reconstitution with allogeneic bone marrow cells, with or without additional anti-cytokine monoclonal antibodies.
    Gorczynski RM, Chen Z, Zeng H, Gorczynski L, Terzioglu E.
    Immunology; 1998 Feb 01; 93(2):221-9. PubMed ID: 9616372
    [Abstract] [Full Text] [Related]

  • 33. The role of purified CD8+ T cells in graft-versus-leukemia activity and engraftment after allogeneic bone marrow transplantation.
    Palathumpat V, Dejbakhsh-Jones S, Strober S.
    Transplantation; 1995 Aug 27; 60(4):355-61. PubMed ID: 7652765
    [Abstract] [Full Text] [Related]

  • 34. Lack of transfer of lpr-type abnormalities (lymphoproliferation or lymphoid aplasia) in double congenic nude beige mice engrafted with lpr haematopoietic cells.
    Tiberghien F, Pflumio F, Kuntz L, Loor F.
    Immunology; 1993 May 27; 79(1):158-66. PubMed ID: 8099566
    [Abstract] [Full Text] [Related]

  • 35. Prevention of lethal graft-versus-host disease in mice by monoclonal antibodies directed against T cells or their subsets. I. Evidence for the induction of a state of tolerance based on suppression.
    Knulst AC, Tibbe GJ, Noort WA, Bril-Bazuin C, Benner R, Savelkoul HF.
    Bone Marrow Transplant; 1994 Mar 27; 13(3):293-301. PubMed ID: 8199571
    [Abstract] [Full Text] [Related]

  • 36. Spontaneous production of interleukin 3 by T lymphocytes from autoimmune MRL/MP-lpr/lpr mice.
    Palacios R.
    Eur J Immunol; 1984 Jul 27; 14(7):599-605. PubMed ID: 6430708
    [Abstract] [Full Text] [Related]

  • 37. Prevention of graft-versus-host disease using antibody to Thy 1. A role for complement in vivo.
    Hamilton BL, Harris D.
    Transplantation; 1985 Jul 27; 40(1):90-6. PubMed ID: 2861676
    [Abstract] [Full Text] [Related]

  • 38. Intermediate TCR cells can induce graft-versus-host disease after allogeneic bone marrow transplantation.
    Weerasinghe A, Kawamura T, Moroda T, Seki S, Watanabe H, Abo T.
    Cell Immunol; 1998 Apr 10; 185(1):14-29. PubMed ID: 9636679
    [Abstract] [Full Text] [Related]

  • 39. The fate of donor T-cell receptor transgenic T cells with known host antigen specificity in a graft-versus-host disease model.
    Dey B, Yang YG, Preffer F, Shimizu A, Swenson K, Dombkowski D, Sykes M.
    Transplantation; 1999 Jul 15; 68(1):141-9. PubMed ID: 10428282
    [Abstract] [Full Text] [Related]

  • 40. The effect of total or partial T lymphocyte depletion on susceptibility to influenza virus infection and development of antiviral immunity in lethally irradiated mice reconstituted with immune syngeneic bone marrow grafts.
    Mumcuoglu M, Zakay-Rones Z, Weiss L, Slavin S.
    Bone Marrow Transplant; 1991 Mar 15; 7(3):217-20. PubMed ID: 1647828
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.